746447
Last Update Posted: 2012-06-26
Recruiting has ended
All Genders accepted | 18 Years-75 Years |
648 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)
This study intends to study the efficacy and tolerability of once daily 3.0 g mesalazine granules vs. once daily 1.5 g mesalazine granules vs. three times daily 0.5 g mesalazine granules for maintenance of remission in patients with ulcerative colitis
Eligibility
Relevant conditions:
Colitis, Ulcerative
Recurrence
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov